AS

Anilkumar Sampatrao Shinde

Director DIN 08386742
DIN 08386742 First appointment Mar 2019
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Anilkumar Sampatrao Shinde

Data last updated:

Anilkumar Sampatrao Shinde was a Director at Hashcure Pharmaceutical Private Limited (from 2020) and Director at Amresh Resources Private Limited (from 2019).

DIN 08386742
First Appointment 12 Mar 2019
Oldest Company Age 7 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Feb 20202020Strike Off
Amresh Resources Private Limited U74999MH2019PTC322403
Director12 Mar 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hashcure Pharmaceutical Private Limited
Amresh Resources Private Limited
Premium access

Shareholding and investment profile for Anilkumar Sampatrao Shinde

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anilkumar Sampatrao Shinde

Anilkumar Sampatrao Shinde was first appointed on 12 Mar 2019 as Director at Amresh Resources Private Limited. The most recent appointment on record is 05 Feb 2020 at Hashcure Pharmaceutical Private Limited.

Anilkumar Sampatrao Shinde held 2 earlier board appointments: Hashcure Pharmaceutical Private Limited (Director, from 05 Feb 2020); Amresh Resources Private Limited (Director, from 12 Mar 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available